Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001-2006

American Journal of Clinical Nutrition

Volumn 94, Issue 1, 2011, Pages 225-233

  Ganji, Vijay ^a   Zhang, Xu ^a   Shaikh, Nida ^a   Tangpricha, Vin ^b,c  

^a GEORGIA STATE UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOMEOSTATIC MODEL ASSESSMENT INSULIN RESISTANCE; HUMAN; HYPERTENSION; IMMUNOASSAY; IMMUNOENZYMOMETRY; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTICENTER STUDY; NATIONAL HEALTH SERVICE; OBESITY; PREVALENCE; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RISK FACTOR; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; UNITED STATES; VITAMIN BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; CHILD; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH SURVEYS; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; PREVALENCE; RISK FACTORS; TIME FACTORS; VITAMIN D;

EID: 79959470968     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.111.013516     Document Type: Article

References (62)

1. Saintonge S, Bang H, Gerber LM. Implications of a new definition of vitamin D deficiency in a multiracial us adolescent population: the National Health and Nutrition Examination Survey III. Pediatrics 2009;123:797-803.
2. Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 2004;158:531-7. (Pubitemid 38720483)
3. Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML. Prevalence and Associations of 25-Hydroxyvitamin D Deficiency in US Children: NHANES 2001-2004. Pediatrics 2009;124:e362-70.
4. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;80:1678S-88S.
5. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001;358:1500-3. (Pubitemid 33055701)
6. Maki KC, Rubin MR, Wong LG, et al. Serum 23-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women. J Clin Lipidol 2009;3:289-96.
7. Baz-Hecht M, Goldfine AB. The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr Opin Endocrinol Diabetes Obes 2010;17:113-9.
8. Judd SE, Nanes MS, Ziegler TR, Wilson PW, Tangpricha V. Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2008;87:136-41.
9. Ganji V, Milone C, Cody MM, McCarthy F, Wang YT. Serum vitamin D concentrations are related to depression in young adult US population: the Third National Health and Nutrition Examination Survey. Int Arch Med 2010;3:29.
10. Spina CS, Tangpricha V, Uskokovic M, Adorinic L, Maehr H, Holick MF. Vitamin D and cancer. Anticancer Res 2006;26:2515-24.
11. Potenza MV, Mechanick JI. The metabolic syndrome: definition, global impact, and pathophysiology. Nutr Clin Pract 2009;24:560-77.
12. Alvarez JA, Ashraf A. Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol 2010;2010:351385.
13. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
14. Duncan GE, Li SM, Zhou XH. Prevalence and trends of a metabolic syndrome phenotype among U.S. Adolescents, 1999-2000. Diabetes Care 2004;27:2438-43.
15. Johnson WD, Kroon JJ, Greenway FL, Bouchard C, Ryan D, Katzmarzyk PT. Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006. Arch Pediatr Adolesc Med 2009;163:371-7.
16. Reis JP, von Muhlen D, Miller ER III, Michos ED, Appel LJ, Vitamin D. Status and cardiometabolic risk factors in the United States adolescent population. Pediatrics 2009;124:e371-9.
17. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005;28:1228-30. (Pubitemid 40616645)
18. Teegarden D, Donkin SS. Vitamin D: emerging new roles in insulin sensitivity. Nutr Res Rev 2009;22:82-92.
19. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79:820-5. (Pubitemid 41103882)
20. Huh SY, Gordon CM. Vitamin D deficiency in children and adolescents: epidemiology, impact and treatment. Rev Endocr Metab Disord 2008;9:161-70.
21. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008;57:2619-25.
22. Alemzadeh R, Kichler J, Babar G, Calhoun M. Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 2008;57:183-91.
23. Reinehr T, de Sousa G, Alexy U, Kersting M, Andler W. Vitamin D status and parathyroid hormone in obese children before and after weight loss. Eur J Endocrinol 2007;157:225-32. (Pubitemid 47233129)
24. Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 2011;57:63-9.
25. Oliveira AC, Oliveira AM, Adan LF, Oliveira NF, Silva AM, Ladeia AM. C-reactive protein and metabolic syndrome in youth: a strong relationship? Obesity (Silver Spring) 2008;16:1094-8.
26. Gillum RF. Association of serum C-reactive protein and indices of body fat distribution and overweight in Mexican American children. J Natl Med Assoc 2003;95:545-52. (Pubitemid 37107833)
27. de Ferranti SD, Rifai N. C-reactive protein: a nontraditional serum marker of cardiovascular risk. Cardiovasc Pathol 2007;16:14-21. (Pubitemid 46049026)
28. Szmitko PE, Verma S. C-reactive protein and the metabolic syndrome: useful addition to the cardiovascular risk profile? J Cardiometab Syndr 2006;1:66-9.
29. Skinner AC, Steiner MJ, Henderson FW, Perrin EM. Multiple markers of inflammation and weight status: cross-sectional analyses throughout childhood. Pediatrics 2010;125:e801-9.
30. Ford ES, Ajani UA, Mokdad AH. The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care 2005;28:878-81. (Pubitemid 40434489)
31. de Ferranti SD, Gauvreau K, Ludwig DS, Newburger JW, Rifai N. Inflammation and changes in metabolic syndrome abnormalities in US adolescents: findings from the 1988-1994 and 1999-2000 National Health and Nutrition Examination Surveys. Clin Chem 2006;52:1325-30.
32. Sun J, Kong J, Duan Y, et al. Increased NF-kappa B activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab 2006;291:E315-22.
33. National Center for Health Statistics. Revised analytic note for NHANES 2000-2006 and NHANES III (1988-1994) 25-hydroxyvitamin D analysis. November 2010. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes3/VitaminD- analyticnote.pdf (cited 3 December 2010).
34. National Center for Health Statistics. National Health and Nutrition Examination Survey analytic and reporting guidelines. 2004. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes-general-guidelines-june-04.pdf (cited 1 December 2010).
35. National Center for Health Statistics. National Health and Nutrition Examination Survey demographic files. 2002. Available from: http://www.cdc.gov/ nchs/nhanes/nhanes2001-2002/DEMO-B.htm (cited 2 December 2010).
36. National Center of Health Statistics. National Health and Nutrition Examination Survey examination files. 2002. Available from: http://www.cdc.gov/ nchs/nhanes/nhanes2001-2002/current-nhanes-01-02.htm (cited 2 December 2010).
37. National Center for Health Statistics. National Health and Nutrition Examination Survey laboratory protocol. 2006. Available from: http://www.cdc.gov/nchs/nhanes/nhanes2005-2006/lab05-06.htm (cited 1 December 2010).
38. National Center for Health Statistics. National Health and Nutrition Examination Survey laboratory protocol. 2004. Available from http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/lab03-04.htm (cited 3 December 2010).
39. National Center for Health Statistics. National Health and Nutrition Examination Survey laboratory protocol. 2002. Available from: http://www.cdc.gov/nchs/nhanes/nhanes2001-2002/lab01-02.htm (cited 1 December 2010).
40. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9. (Pubitemid 15018832)
41. Le Stunff C, Dechartres A, Miraglia Del Giudice E, Froguel P, Bougneres P. A single-nucleotide polymorphism in the p110beta gene promoter is associated with partial protection from insulin resistance in severely obese adolescents. J Clin Endocrinol Metab 2008;93:212-5.
42. Mansbach JM, Ginde AA, Camargo CA Jr. Serum 25-hydroxyvitamin D levels amond US children aged 1-11 years: do children need more vitamin D? Pediatrics 2009;124:1404-10.
43. Yetley EA, Pfeiffer CM, Schleicher RL, et al. NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary. J Nutr 2010;140:2030S-45S.
44. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008;88:1519-27.
45. Kelly A, Brooks LJ, Dougherty S, Carlow DC, Zemel BS. A crosssectional study of vitamin D and insulin resistance in children. Arch Dis Child (Epub ahead of print 20 February 2011).
46. Muldowney S, Kiely M. Vitamin D and cardiometabolic health: a review of the evidence. Nutr Res Rev 2010;24:1-20.
47. Smotkin-Tangorra M, Purushothaman R, Gupta A, Nejati G, Anhalt H, Ten S. Prevalence of vitamin D insufficiency in obese children and adolescents. J Pediatr Endocrinol Metab 2007;20:817-23. (Pubitemid 47322709)
48. Pittas AG, Bess Dawson-Hughes B. Vitamin D and diabetes. J Steroid Biochem Mol Biol 2010;121:425-9.
49. Oh JY, Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community- dwelling older adults: the Rancho Bernardo Study. Metabolism 2002;51:356-9. (Pubitemid 34232638)
50. Reis AF, Hauache OM, Velho G. Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease: a review of evidence. Diabetes Metab 2005;31:318-25. (Pubitemid 41391473)
51. Reis JP, von Muhlen D, Miller ER III. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol 2008;159:41-8. (Pubitemid 351969129)
52. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690-3. (Pubitemid 30667088)
53. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008;122:398-417.
54. Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007;49:1063-9. (Pubitemid 351664326)
55. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002;110:229-38.
56. Ballermann BJ, Marsden PA. Endothelium-derived vasoactive mediators and renal glomerular function. Clin Invest Med 1991;14:508-17.
57. Resnick LM, Muller FB, Laragh JH. Calcium-regulating hormones in essential hypertension: relation to plasma renin activity and sodium metabolism. Ann Intern Med 1986;105:649-54. (Pubitemid 17176965)
58. Morse SA, Zhang R, Thakur V, Reisin E. Hypertension and the metabolic syndrome. Am J Med Sci 2005;330:303-10. (Pubitemid 41831901)
59. Goossens GH, Blaak EE, van Baak MA. Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders. Obes Rev 2003;4:43-55. (Pubitemid 36356409)
60. Xiang W, Kong J, Chen S, et al. Cardiohypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systmes. Am J Physiol Endocrinol Metab 2005;288:E125-32.
61. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1,25- Dihydroxyvitamin D3 receptors in human leukocytes. Science 1983;221:1181-3.
62. Shea MK, Booth SL, Massaro JM, et al. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol 2008;167:313-20. (Pubitemid 351197593)